Avatrial exists to save the lives of cancer patients by accelerating the global mission towards superior personalised treatments for every patient. We do this by generating data that will help us understand cancer better, to develop more effective therapies and to predict patient responses to treatment. 

Avatrial is an end-to-end cancer drug discovery company redesigning how therapies are developed. We integrate proprietary full-stack multi-omic data from matched tumour and healthy patient samples, AI-driven insights, and in-house experimental validation, including tumour organoids. By eliminating noise and waste at every step of discovery, we deliver better cancer therapies faster. Our platform generates high-quality datasets, predictive analytics, and clinically relevant models, enabling partnerships with hospitals, pharmaceutical companies, and technology leaders worldwide to accelerate the development of more effective, personalised cancer treatments.

Contact us to join us in our mission.

Avatrial

Org chart

Teams

Offices